Outside of previously mentioned diseases, the genome-wide association study (GWAS) database reveals SNPs in MINK1 amyotrophic lateral sclerosis, bipolar disorder, astigmatism, breast neoplasms, prostatic neoplasms, Crohn’s disease, insulin resistance, Parkinson’s disease, Hodgkin disease, schizophrenia, and type II diabetes (GWAS Central at www.gwascentral.org, accessed on 28 November 2024 [216]), which is a significant foundation for future studies. This evidence concerns the gene MINK1 and schizophrenia.